Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

Clicks: 505
ID: 117158
2009
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #9 of 46 articles by views in the pediatric infectious disease journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
: After 6 months of HAART, more than half of previously immunized children still lacked positive measles antibody. With increased use of HAART in pediatric populations, revaccination against measles and tetanus should be considered to boost response rates and immunization coverage.
Reference Key
c2009theimmune Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Farquhar C;Wamalwa D;Selig S;John-Stewart G;Mabuka J;Majiwa M;Sutton W;Haigwood N;Wariua G;Lohman-Payne B;;
Journal the pediatric infectious disease journal
Year 2009
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19258919
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine statistical research support female male N.I.H. Extramural Child preschool Antibodies hiv-1* Cohort Studies anti-hiv agents / therapeutic use kenya immunoglobulin g / blood data interpretation bacterial / blood antiretroviral therapy hiv infections / immunology* measles vaccine / immunology* highly active* hiv infections / drug therapy* tetanus toxoid / immunology* measles vaccine / administration & dosage tetanus toxoid / administration & dosage pmid:19258919 pmc2779204 doi:10.1097/inf.0b013e3181903ed3 carey farquhar dalton wamalwa barbara lohman-payne secondary

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.